· 19/03/2014

TREND: Estudio fase IIIb multicentrico, randomizado, de 12 meses de seguimiento con evaluador de la agudeza visual enmascarado, para evaluar la eficacia y la seguridad de ranibizumab 0,5mg en un régimen de tratar e extender comparado con un régimen mensual, en pacientes con degeneración macular neovascular asociada a la edad

· 19/03/2014

MACBETH. Assaig clínic en fase IV per a avaluar l’eficàcia d’aflibercept a pacients amb degeneració macular associada a l’edat (DMAE) neovascular, sense resposta optima a repetides injeccions mensuals intravitrees d’anti VEGF-A

· 23/01/2014

Advocating for Improved treatment and Outcomes for Wet Age-related Macular Degeneration. A report based on an International Expert Summit.

· 30/01/2014

Expert Clinical Guide to the Management of Exudative Age-Related Macular Degeneration

· 30/09/2013

Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case report. 2013.

· 31/08/2013

Intravitreal Injections: A Healthcare Failure Modes and Effects Analysis. 2013, Aug.

· 01/04/2012

Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration.

· 01/07/2012

Hyporeflective wedge-shaped band in geographic atrophy secondary to age-related macular degeneration: a little-understood spectral domain optical coherence tomography finding.

· 01/12/2012

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and high visual acuity.

· 01/07/2011

Update on Geographic Atrophy in Age-Related Macular Degeneration.

· 01/04/2010

Ranibizumab in the treatment of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome.

· 01/05/2011

Management of Retinal Vein Occlusion – Consensus Document.

· 01/02/2010

Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration.

· 24/04/2010

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

· 01/12/2011

Postsurgical cystoid macular edema